These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 7599570

  • 1. Granisetron in the prevention of irradiation-induced emesis.
    Prentice HG, Cunningham S, Gandhi L, Cunningham J, Collis C, Hamon MD.
    Bone Marrow Transplant; 1995 Mar; 15(3):445-8. PubMed ID: 7599570
    [Abstract] [Full Text] [Related]

  • 2. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B, Ippoliti C, Bruton J, Neumann J, Whaley R, Champlin R.
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W.
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J.
    Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
    [Abstract] [Full Text] [Related]

  • 5. Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation.
    Hunter AE, Prentice HG, Pothecary K, Coumar A, Collis C, Upward J, Murdoch R, Gandhi L, Hamon M, Butler M.
    Bone Marrow Transplant; 1991 Jun; 7(6):439-41. PubMed ID: 1651794
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP, Fisher SG, Kiley K, Fletcher-Gonzalez D, Porter N, Stiff P.
    Biol Blood Marrow Transplant; 2001 Jun; 7(11):596-603. PubMed ID: 11760147
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    Hirabayashi N, Goto S, Morishima Y, Sao H, Matsuyama T, Kodera Y, Yamada H, Horibe K, Yano K, Kojima H, Ogura M, Tanimoto M, Morishita Y, Yazaki M, Utsumi M, Nagata K, Kato Y, Naoe T, Saito H.
    Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
    Chevallier B.
    Eur J Cancer; 1990 Jan; 26 Suppl 1():S33-6. PubMed ID: 2169784
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
    Marty M.
    Eur J Cancer; 1990 Jan; 26 Suppl 1():S28-32. PubMed ID: 2169783
    [Abstract] [Full Text] [Related]

  • 10. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA, Lembersky B, Kaywin P, Kalman L, Yocom K, Friedman C.
    Cancer J Sci Am; 1998 Jan; 4(1):52-8. PubMed ID: 9467047
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [Abstract] [Full Text] [Related]

  • 12. [Value of granisetron in the prevention of digestive disorders in total body irradiation].
    Feuvret L, Jammet P, Campana F, Cosset JM, Fourquet A.
    Bull Cancer Radiother; 1994 Oct; 81(1):41-4. PubMed ID: 7893522
    [Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
    Ettinger DS, Eisenberg PD, Fitts D, Friedman C, Wilson-Lynch K, Yocom K.
    Cancer; 1996 Jul 01; 78(1):144-51. PubMed ID: 8646710
    [Abstract] [Full Text] [Related]

  • 14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 15. Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.
    Okamoto S, Takahashi S, Tanosaki R, Sakamaki H, Onozawa Y, Oh H, Miyawaki S, Kimura Y, Toyama K, Ikeda Y, Asano S.
    Bone Marrow Transplant; 1996 May 01; 17(5):679-83. PubMed ID: 8733681
    [Abstract] [Full Text] [Related]

  • 16. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD.
    Cancer J Sci Am; 1997 May 01; 3(3):180-3. PubMed ID: 9161784
    [Abstract] [Full Text] [Related]

  • 17. A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin. The Italian Multicenter Study Group.
    Anticancer Drugs; 1999 Jun 01; 10(5):465-70. PubMed ID: 10477166
    [Abstract] [Full Text] [Related]

  • 18. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Mabro M, Granisétron PK.
    Bull Cancer; 1999 Mar 01; 86(3):295-301. PubMed ID: 10210764
    [Abstract] [Full Text] [Related]

  • 19. Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone.
    Heron JF.
    Semin Oncol; 1995 Aug 01; 22(4 Suppl 10):24-30. PubMed ID: 7570051
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.